Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
Jason Grebely, Truong Pham Son, Gail V Matthews, Kathy Petoumenos, Rowena A Bull, Barbara Yeung, William Rawlinson, John Kaldor, Andrew Lloyd, Margaret Hellard, Gregory J Dore, Peter A White
Hepatology | WILEY | Published : 2012
Awarded by National Institutes of Health
Awarded by NATIONAL INSTITUTE ON DRUG ABUSE
This study was funded by the National Institutes of Health grant RO1 DA 15999-01. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. Roche Pharmaceuticals supplied financial support for pegylated IFN-alfa-2a/ribavirin. STP was supported by a University International Postgraduate Award. GD and AL were supported by National Health and Medical Research Council Practitioner Research Fellowships. MH was supported by a National Health and Medical Research Council Career Development Award and a VicHealth Senior Research Fellowship. JK and RB were supported by National Health and Medical Research Council Research Fellowships.